"Recently, the U.S. Food and Drug Administration (FDA) approved a vaccine that is highly effective in preventing infection with types 16 and 18, two “high-risk” HPVs that cause most (70 percent) cervical cancers, and types 6 and 11, which cause most (90 percent) genital warts (4)."
source: http://www.cancer.gov/cancertopics/factsheet/Risk/HPV, the national cancer institute, part of the national institutes of health
![[identity profile]](https://www.dreamwidth.org/img/silk/identity/openid.png){kind=small}
![[personal profile]](https://www.dreamwidth.org/img/silk/identity/user.png)
timeasmymeasure
no subject
Date: 2006-12-01 01:12 am (UTC)"Recently, the U.S. Food and Drug Administration (FDA) approved a vaccine that is highly effective in preventing infection with types 16 and 18, two “high-risk” HPVs that cause most (70 percent) cervical cancers, and types 6 and 11, which cause most (90 percent) genital warts (4)."
source: http://www.cancer.gov/cancertopics/factsheet/Risk/HPV, the national cancer institute, part of the national institutes of health